Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report

Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report

Abstract Background Nivolumab is an immune checkpoint inhibitor (ICI) and is used for the treatment of advanced non-small cell lung cancer (NSCLC). Several immune-mediated neurological adverse events associated with ICIs have been reported to date, such as Guillain-Barré syndrome. Nivolumab-associat...

Full description

Bibliographic Details
Main Authors: Takashi Sakoh, Mami Kanzaki, Atsushi Miyamoto, Sayaka Mochizuki, Toshiyuki Kakumoto, Kenichiro Sato, Yoshikazu Uesaka, Kazuma Kishi
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Cancer
Subjects:
Immune checkpoint inhibitor
Intravenous immunoglobulin
Lung cancer
Neurological adverse events
Nivolumab
Ramsay-Hunt syndrome
Online Access:https://doi.org/10.1186/s12885-019-6444-0

Internet

https://doi.org/10.1186/s12885-019-6444-0

Similar Items